Catalyst
Slingshot members are tracking this event:
DUPIXENT (dupilumab) for Moderate-to-Severe Asthma PDUFA date set for October 20, 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| REGN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 19, 2018
Occurred Source:
https://newsroom.regeneron.com/news-releases/news-release-details/fda-approves-asthma-indication-dupixentr-dupilumab
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Liberty Asthma, Pdufa Date, Cytokines, Asthma, Phase 3 Quest
